Skip to main content
Premium Trial:

Request an Annual Quote

Harold Safferstein, Samuel Straface, David Weaver, Raymond DeVito, Mark Nuell

Premium
The Pittsburgh Life Sciences Greenhouse last week announced the addition of Harold Safferstein, Samuel Straface, and David Weaver to its management team.
 
Safferstein previously served as vice president of business development for Omrix Biopharmaceuticals. Prior to this, he was executive vice president of corporate development for TransPharma Medical. Safferstein has also served as vice president of business development for Accordia Therapeutics, and in various business development and marketing positions with Bristol-Myers Squibb. From 1991 to 1997, he served as director of technology transfer for the National Heart, Lung and Blood Institute, and cooperative venture manager for the National Institute of Allergy and Infectious Diseases.
 
Straface was founding president and CEO of Triton Biosystems. He previously served as director of the new ventures group at Boston Scientific and general manager for several business groups at Johnson & Johnson in Australia. Prior to this, he held a number of positions at Ethicon Endo-Surgery, a J&J company. Straface also co-founded Sensera, a development-stage biological sensor company.
 
Weaver was the founder and president of Great Lakes Angels, a member of the board of directors for Detroit MIT Enterprise Forum, and a founding member of Michigan Venture Capital Association. Weaver also was responsible for global profit/loss at a division of Johnson & Johnson, and held various business operations positions at Warner-Lambert.
 

 
The Utah State University Technology Commercialization Office last week named Raymond DeVito as director.
 
DeVito previously served as the USU physical sciences commercialization director, and he also holds an appointment as adjunct professor of physics. DeVito came to USU after working as director of research for Siemens Medical Systems. DeVito was also founder, CEO, and president of Mosaic Imaging Technology. He holds a BS in physics from Rutgers University and a PhD in physics from Michigan State Univeristy. DeVito is also a registered patent agent with the US Patent and Trademark Office.
 

 
Intellectual property law firm Birch, Stewart, Kolasch & Birch last week announced the appointment of Mark Nuell as partner in the firm’s biotechnology practice in its San Diego office.
 
Nuell was previously a partner in the firm’s East coast office, located in Falls Church, Va. He holds a PhD from the University of Illinois and a law degree from George Mason University School of Law.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more